Literature DB >> 20804546

The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects.

Halide S Akbas1, Sebahat Basyigit, Inci Suleymanlar, Didem Kemaloglu, Serkan Koc, Fatih Davran, Ibrahim Demir, Gultekin Suleymanlar.   

Abstract

BACKGROUND: The role of inflammation in the pathogenesis and progression of atherosclerosis has been increasingly discussed. Although the seroepidemiological studies have suggested a relationship between Helicobacter pylori (H. pylori) infection and atherosclerosis; the issue is still controversial. It is well known that abnormal lipid profil is related to atherosclerosis and the measurement of carotid-intima media thickness (CIMT) is one of the surrogate marker of atherosclerosis. The serum concentration of high-density lipoprotein (HDL-C) has been known to have an inverse correlation with the development of atherosclerosis. Paraoxonase-1 (PON1) is a major anti-atherosclerotic component of HDL-C. PON1 activity is related to lipid peroxidation and prospective cardiovascular risk. The aim of this study was to investigate CIMT and serum PON1 activities along with lipid parameters in H. pylori positive and negative subjects.
METHODS: Thirty H. pylori positive subjects and thirty-one negative subjects were enrolled. H. pylori infection was diagnosed by the presence of positivity of stool H. pylori antigen test or Carbon 14 labeled urea breath test. Serum PON1 activity was measured spectrophotometrically. Traditional cardiovascular risk factors were investigated and laboratory analysis included measurement of serum triglycerides (TG), total cholesterol (TC), high-density lipoprotein (HDL-C) and low-density lipoprotein cholesterol (LDL-C). We assessed CIMT by high-resolution ultrasound of both common carotid arteries.
RESULTS: We found that the mean and maximum values of right and overall CIMT in H. pylori positive subjects were significantly thicker than those of H. pylori negative subjects. There was no significant differences in serum HDL-C, LDL-C, TC levels and TC/HDL-C ratios between two groups. Serum TG levels of H. pylori positive subjects were significantly higher than those of H. pylori negative subjects (p = 0.014). We found that PON1 activities were significantly lower in H. pylori positive subjects compared with negative subjects. No significantly correlation was observed between PON1 and CIMT values.
CONCLUSIONS: There is an increase in CIMT values in patients with H. pylori positive compared to H. pylori negative subjects. PON1 activity decrease significantly in H. pylori positive subjects. However, an association between PON1 and CIMT was not found. These data indicated that H. pylori may have a role in atherosclerotic processes, however, further studies are needed to evaluate the exact mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20804546      PMCID: PMC2936361          DOI: 10.1186/1476-511X-9-92

Source DB:  PubMed          Journal:  Lipids Health Dis        ISSN: 1476-511X            Impact factor:   3.876


Introduction

Helicobacter pylori is a gram negative curved bacillus that is frequently found in the human stomach and causes chronic and active gastritis, peptic ulcer disease and is associated with gastric adenocarcinoma [1,2]. Several studies have demonstrated that H. pylori infection is also associated with the development of coronary atherosclerosis [3]. Atherosclerosis pathogenesis includes abnormal lipid metabolism, endothelial dysfunction, inflammatory and immunological factors, plaque rupture and smoking [4]. Infectious processes can contribute to the pathogenesis of atherosclerosis by producing chronic infection of the vessels with inflammation leading to endothelial dysfunction [5]. It has been suggested that exposure to sustained high levels of endotoxin constitute a risk factor for atherosclerosis in animal models and, likely, in humans [5,6]. A low concentration of HDL-C is a well-known risk factor for coronary heart disease [5]. There are several well-documented functions of high plasma levels of HDL-C preventing the development of atherosclerosis. Most important function of HDL is to promote the efflux of cholesterol from cells. HDL-C also possesses antioxidant and antiinflammatory activities. The antioxidant activity of HDL-C is largely due to its paraoxonase-1 (PON1) content [7]. Human serum paraoxonase (PON1), a high-density lipoprotein (HDL)-bound ester hydrolase enzyme, has been shown to protect LDL from in vitro oxidation by hydrolysis of biologically active lipoperoxides [4]. Animal studies, including PON1-knockout mouse, demonstrated that PON1 deficiency was shown to increase susceptibility to LDL oxidation and atherosclerosis development [8]. In humans, it has been suggested that PON1 is significantly associated with atherosclerotic risk. PON1 activity is geneticly regulated and varies widely among populations [9]. Previous studies have shown LDL oxidation and the degradation of PON1 activity were significantly correlated [10]. Although serum PON1 activity in patients with coronary heart disease is decrease and is negatively related to the severity of coronary artery lesions, the correlation between PON1 activity and CIMT is controversial [11,12]. Existing cardiovascular diseases (CVDs) are found to be correlated with carotid artery intima-media thickness (CIMT) measured by ultrasound and are predictive of CVD in individuals without clinically evident disease. CIMT is now widely used as a early marker for atherosclerotic disease [13]. The aim of the present study was to evaluate the association between serum PON-1 activities and CIMT values in patients with H. pylori. For this purpose, we measured the CIMT and we compared the serum PON-1 activity and blood lipids between H. pylori positive and negative subjects.

Materials and methods

Patients

This study was approved by institutional ethical committee of Akdeniz University, Faculty of Medicine. The subjects were selected among adults who visited the Department of Gastroenterology because of dyspeptic symptoms and were tested for H. pylori infection in Akdeniz University Hospital, between August and November 2009. H. pylori infection was identified by the presence of positivity of H. pylori stool antigen test or Carbon 14 labeled urea breath test. We excluded patients who had acute infectious, rheumatologic and cardiovascular disease. For the study we included 30 H. pylori infected individuals (14 male and 16 female). 31 healthy noninfected, (15 male and 16 female), age and sex matched individuals were enrolled in this study for a control. All subjects were informed about the study and the written consent was obtained. We obtained detailed medical history about smoking habits, the presence of diabetes mellitus, hypertension, hyperlipidemia, family history of cardiovascular.disease and medication including antihypertensive and antihyperlipidemic drugs. Blood pressure was measured with manual sphygmomanometer. Body mass index (BMI; kg/m2) was calculated by dividing the body weight (kg) with squared height (m2). Their routine laboratory tests which contain complete blood count, serum glucose, creatinine and alanin aminotransferase (ALT) levels were recorded.

Measurement of Serum Lipid and Lipoprotein Levels

Venous blood samples were obtained following an overnight fasting state. Serum samples were separated and stored at -80°C until the analysis. Serum total cholesterol (TC), HDL cholesterol (HDL-C) and triglyceride (TG) levels were measured with the enzymatic colorimetric method by using commercial kits on a Modular PPP auto-analyzer (Roche Diagnostics). Serum LDL-C levels were calculated by using Friedewald formula [14]. Serum TC/HDL-C ratio was also calculated. This ratio represents an atherogenic index, which is an important prognostic marker for cardiovascular disease [15].

Measurement of Serum PON1 Activity

Serum PON1 activity was measured by adding serum to Tris buffer (100 mmol/L, pH 8.0) containing 2 mmol/L CaCl2 and 5.5 mmol/L paraoxon (O, O-diethyl-O-p-nitrophenylphosphate; Sigma Chemical Co). The rate of generation of p-nitrophenol was determined at 405 nm. according to MacKness B et al. [16]. The method was applied to an automated analyzer (Syva V-Twin, Siemens Diagnostics). The results are expressed as U/L.

Ultrasound Scanning Procedure

Subjects were evaluated for carotid intima media thickness (CIMT) and plaque occurrence by using high resolution grey-scale Doppler ultrasonography. In a semi-dark room, all subject lay supine with their necks slightly hyperextended and rotated away from the imaging transducer. Both carotid arteries were scanned. CIMT was defined as the distance between the leading edge of the lumen intimal interface and the leading edge of the media adventitia interface of the far wall [13].

Statistical Analysis

Data analysis was done with a statistical software package (SPSS for Windows, Version 16.0, SPSS Inc, and Chicago, Ill). Quantitative data were expressed as mean (± SD) or as medians. The comparisons of parameters were performed using Student's t-test. Correlation analyses were performed using Pearson's correlation test. A p-value of < 0.05 was considered as significant.

Results

We included 30 subjects (14 male, 16 female) infected with H. pylori and 31 subjects (15 male, 16 female) without H. pylori infection. The demographic and clinical characteristics of study population are shown in Table 1. There were no statistically significant differences between two groups with regard to demographic and clinical characteristics (age, gender, BMI, smoking habits; history of diabetes mellitus; hypertension; family history for CVD).
Table 1

Demographic and Clinical Characteristics of Helicobacter pylori positive and negative subjects

ParameterH. pylori positive subjects(n = 30)H. pylori negative subjects(n = 31)p value
Age (years)40.9 ± 10.342.3 ± 9.4NS

Gender M/F13/1714/16NS

DM12NS

HT44NS

HPL810NS

Smoking1215NS

Family history of CVD34NS

Systolic BP (mmHg)119 ± 3121 ± 8NS

Diastolic BP (mmHg)78.5 ± 8.879 ± 6.6NS

BMI (kg/m2)27.1 ± 3.726.2 ± 3.8NS

Results are expressed as mean ± SD or number of patients.

Abbreviations: DM: diabetes mellitus, HT: hypertension, HPL: hyperlipidemia, CVD: cardiovascular disease, Systolic BP: systolic blood pressure, Diastolic BP: diastolic blood pressure. BMI: body mass index, NS: non-significant

Demographic and Clinical Characteristics of Helicobacter pylori positive and negative subjects Results are expressed as mean ± SD or number of patients. Abbreviations: DM: diabetes mellitus, HT: hypertension, HPL: hyperlipidemia, CVD: cardiovascular disease, Systolic BP: systolic blood pressure, Diastolic BP: diastolic blood pressure. BMI: body mass index, NS: non-significant As shown in Table 2; serum TG levels were significantly higher in H. pylori positive subjects than H. pylori negative subjects (1.81 ± 0.79 mmol/L vs 1.32 ± 0.73 mmol/L, p < 0.05). There were no statistically significant differences in TC, HDL-C, LDL-C levels and TC/HDL-C ratios between the two groups. Serum PON1 activity was significantly lower in H. pylori positive subjects when compared with negative subjects (270.03 ± 84.82 vs 340.00 ± 123.70 U/L, p < 0.05).
Table 2

Biochemical variables in Helicobacter pylori positive and negative subjects

ParameterH. pylori positive subjects(n = 30)H. pylori negative subjects(n = 31)p value
Hb (g/dL)13.6 ± 1.813.8 ± 1.5NS

WBC (×10'/L)7.38 ± 1.457.56 ± 1.98NS

Glu (mmol/L)5.44 ± 2.144.95 ± 0.67NS

ALT (U/L)28.4 ± 2125.6 ± 23NS

TC (mmol/L)4.47 ± 1.324.69 ± 0.98NS

LDL-C (mmol/L)2.74 ± 0.802.84 ± 0.77NS

HDL-C (mmol/L)1.15 ± 0.301.21 ± 0.38NS

TG (mmol/L)1.81 ± 0.791.32 ± 0.73*< 0.05

Cr (μmol/L)63.64 ± 13.2668.06 ± 9.72NS

TC/HDL-C4.13 ± 1.654.27 ± 1.95NS

PON1 (U/L)270.03 ± 84.82340.00 ± 123.70*< 0.05

Abbreviations: Hb: Hemoglobin, WBC: White blood cell, Glu: Glucose, ALT, Alanin amino transferase, TC: Total cholesterol, LDL-C: Low density lipoprotein- cholesterol, HDL-C: High density lipoprotein- cholesterol, TG: triglyceride, Cr: Creatinine, TC/HDL-C: Total cholesterol/HDL cholesterol, PON1: paraoxonase-1, NS: non-significant.

Results are expressed as mean ± SD. * p < 0.05 statistically significant

Biochemical variables in Helicobacter pylori positive and negative subjects Abbreviations: Hb: Hemoglobin, WBC: White blood cell, Glu: Glucose, ALT, Alanin amino transferase, TC: Total cholesterol, LDL-C: Low density lipoprotein- cholesterol, HDL-C: High density lipoprotein- cholesterol, TG: triglyceride, Cr: Creatinine, TC/HDL-C: Total cholesterol/HDL cholesterol, PON1: paraoxonase-1, NS: non-significant. Results are expressed as mean ± SD. * p < 0.05 statistically significant Structural measurements of vessels for H. pylori positive and negative subjects at enrollment are shown in Table 3. Atherosclerotic plaques in the common carotid artery were shown in 1% (3 of 30) of H. pylori positive patients and only 0.3% (1 of 30) of control subjects. The mean and maximum values of right CIMT were significantly increased in H. pylori positive subjects compared with negative subjects (p < 0.05). The mean and maximum values of left CIMT were tend to be higher in subjects with H. pylori but the differences were not statistically significant between two groups. We calculated mean and maximum overall CIMT by using left and right CIMT measurements. The mean and maximum values of overall CIMT were significantly higher in H. pylori positive subjects than negative subjects (p < 0.05) (Table 3).
Table 3

Structural and functional parameters of vessels for Helicobacter pylori positive and negative subjects

ParameterH. pylori positive subjects(n = 30)H. pylori negative subjects(n = 31)p value
Mean Right CIMT (mm)0.70 ± 0.090.64 ± 0.06< 0.05

Max Right CIMT (mm)0,81 ± 0,100.74 ± 0.07< 0.05

Mean Left CIMT (mm)0.72 ± 0.140.67 ± 0.08NS

Max Left CIMT (mm)0.83 ± 0.150.79 ± 0.1NS

Mean Overall CIMT (mm)0.71 ± 0.100.65 ± 0.06< 0.05

Max Overall CIMT (mm)0.82 ± 0.110.77 ± 0.01< 0.05

Plaque31

Abbreviations: CIMT: Carotis intima-media thickness, NS: non-significant Results are expressed as mean ± SD or number of patients

* p < 0.05 statistically significant

Structural and functional parameters of vessels for Helicobacter pylori positive and negative subjects Abbreviations: CIMT: Carotis intima-media thickness, NS: non-significant Results are expressed as mean ± SD or number of patients * p < 0.05 statistically significant In H. pylori positive subjects, serum PON1 activities were significantly correlated with HDL-C (r = 0.732, p < 0.05), with TG (r = -0.689, p < 0.05) and TC/HDL-C ratio (r = -0.334, p < 0.05). Serum HDL-C levels were significantly correlated with mean (r = -0.348, p < 0.05) and maximum (r = -0.366, p < 0.05) right CIMT, mean (r = -0.403, p < 0.05) and maximum (r = -0.403, p < 0.05) overall CIMT values while no correlation was found with mean and maximum left CIMT values (p > 0.05). We did not found any significant correlation between PON1 and CIMT values. In H. pylori negative subjects, serum PON1 activities were significantly correlated with TG (r = -0.398, p < 0.05), HDL-C (r = 0.938, p < 0.05) and TC/HDL-C ratio (r = -0.628, p < 0.05). We did not find any significant correlation between serum PON1 activities and CIMT values (all p > 0.05).

Discussion

A relation between atherosclerosis and chronic H. pylori infection was found in epidemiological studies [17-19]. Pellicano et al. reported significantly higher prevalence of H. pylori infection in patients with CAD than in controls (77% vs 59%) [20]. Although these studies have suggested a relationship between H. pylori infection and coronary heart disease; some of the underlying mechanisms still need to be discovered. It has been reported that chronic H. pylori infection results in decreased HDL-C levels, and these lipid alterations could, partially contribute to the initiation and development of coronary atherosclerosis [5,21,22]. Infection and inflammation are associated with a decrease in HDL-C levels. Induction of changes in lipoproteins by cytokines indirectly predisposes patients to atherosclerosis [23]. In the present study, we did not find any significant difference in TC, HDL-C, LDL-C levels and TC/HDL-C ratios between H. pylori positive and negative subjects. However, H. pylori positive subjects had significantly higher plasma triglyceride levels than negative subjects. Laurila et al. found significantly increased triglyceride (1.17 vs 1.00 mmol/L) and total cholesterol (6.34 vs 5.87 mmol/L) levels in 460 H. pylori positive subjects compared with 269 H. pylori negative subjects but HDL-C levels were found to be similar in both groups [24]. Major risk factors of atherosclerosis may explain only 50% of its etiology. Therefore, looking for new risk factors of atherosclerosis is necessary. HDL-C is a well known parameter inversely related to the risk for CVD. It plays a key role in the reverse cholesterol transport, protects LDL against oxidation and reduces lipoprotein associated peroxides. The antioxidant characteristics of HDL-C have been attributed to PON 1. In recent years, authors have suggested that low PON1 activity and concentration were important determinants of the presence of coronary artery disease [25]. Several factors like nutritional, pharmacological, genetic and infectious processes have been demonstrated to modulate PON1 levels [9]. Relationship between PON1 activity and infectious pathogens like HCV and HIV have been shown [26,27]. But, association between H. pylori infection and PON1 has been reported in only one study [4]. Aslan et al. found decreased serum PON1 activity in H. pylori positive patients [4]. In our study we also observed that serum PON1 activity was significantly lower in H. pylori positive subjects when compared with negative subjects. There is considerable evidence suggesting that ultrasonic measurements of early atherosclerosis are clinically significant. In prospective studies increased IMT has been related to an increased risk of cardiovascular diseases [28,29]. There is conflicting data regarding CIMT and H. pylori infection. Some researchers have reported no relationship between H. pylori and CIMT [23,30,31]. However, Hamed et al. reported significant association between the two in diabetic patients [32]. In our study, the mean and maximum values of right and overall CIMT were significantly increased in H. pylori positive subjects compared with negative subjects. The mean and maximum values of left CIMT tended to be higher in H. pylori infected subjects but the differences were not significant between the two groups. We determined the correlations between PON1, HDL-C and CIMT respectively. While CIMT was negatively correlated to HDL-C, it showed no correlation with PON1. As is reported by Chen et al., HDL-C is a complex particle populated by multiple proteins that play a critical role in determining the overall effects of the lipoprotein [33]. Our results demonstrate that, PON 1 singularly could not represent the overall antioxidative activity of HDL-C. The current study has certain limitations. Our study group was limited. We did not perform endoscopy and determine the grade of gastric inflammation or virulence factors of H. pylori. In conclusion; serum PON1 activities were lower in H. pylori positive subjects while right and overall CIMT were significantly higher. Although we found no correlation between CIMT and PON1, these results implied that decreased PON1 activity may have an important role on vascular structural changes induced by H. pylori infection. Further studies with larger populations are needed to explore whether there is a strong relationship between PON1 activity and atherosclerosis in H. pylori infection.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

SHA participated in the design of study and performed the biochemical analysis. FD performed the statistical analysis. SB, IS, GS participated in the coordination of study. DK, SK, ID performed CIMT measurements. All authors read and approved the final manuscript.
  33 in total

1.  Helicobacter pylori infection, the cytotoxin gene A strain, and carotid artery intima-media thickness.

Authors:  Hugh S Markus; Paul Risley; Michael A Mendall; Helmuth Steinmetz; Matthias Sitzer
Journal:  J Cardiovasc Risk       Date:  2002-02

2.  Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis.

Authors:  M Boers; M T Nurmohamed; C J A Doelman; L R Lard; A C Verhoeven; A E Voskuyl; T W J Huizinga; R J van de Stadt; B A C Dijkmans; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

3.  Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile.

Authors:  A Hoffmeister; D Rothenbacher; G Bode; K Persson; W März; M A Nauck; H Brenner; V Hombach; W Koenig
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-03       Impact factor: 8.311

4.  Relationship between high density lipoprotein antioxidant activity and carotid arterial intima-media thickness in patients with essential hypertension.

Authors:  Xiaoping Chen; Yuelei Wu; Liyun Liu; Yanling Su; Yong Peng; Lingyun Jiang; Xiaojing Liu; Dejia Huang
Journal:  Clin Exp Hypertens       Date:  2010-01       Impact factor: 1.749

Review 5.  Helicobacter pylori: from the stomach to the heart.

Authors:  R Pellicano; N Broutet; A Ponzetto; F Mégraud
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-11       Impact factor: 2.566

Review 6.  Surrogate markers of atherosclerosis: impact of statins.

Authors:  John J P Kastelein; Albert Wiegman; Eric de Groot
Journal:  Atheroscler Suppl       Date:  2003-03       Impact factor: 3.235

7.  The paraoxonase promoter polymorphism (-107)T>C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients.

Authors:  Salvatore Campo; Maria A Sardo; Giuseppe Trimarchi; Michele Bonaiuto; Maria Castaldo; Luisa Fontana; Antonio Bonaiuto; Alessandra Bitto; Carlo Saitta; Antonino Saitta
Journal:  Clin Biochem       Date:  2004-05       Impact factor: 3.281

8.  Predisposition to atherosclerosis by infections: role of endothelial dysfunction.

Authors:  Abhiram Prasad; Jianhui Zhu; Julian P J Halcox; Myron A Waclawiw; Stephen E Epstein; Arshed A Quyyumi
Journal:  Circulation       Date:  2002-07-09       Impact factor: 29.690

9.  Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.

Authors:  Orit Rozenberg; Mira Rosenblat; Raymond Coleman; Diana M Shih; Michael Aviram
Journal:  Free Radic Biol Med       Date:  2003-03-15       Impact factor: 7.376

Review 10.  Paraoxonase, a cardioprotective enzyme: continuing issues.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  Curr Opin Lipidol       Date:  2004-06       Impact factor: 4.776

View more
  24 in total

1.  Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease.

Authors:  Yoshio Sumida; Kazuyuki Kanemasa; Shunsuke Imai; Kojiro Mori; Saiyu Tanaka; Hideto Shimokobe; Yoko Kitamura; Kohei Fukumoto; Akira Kakutani; Tomoyuki Ohno; Hiroyoshi Taketani; Yuya Seko; Hiroshi Ishiba; Tasuku Hara; Akira Okajima; Kanji Yamaguchi; Michihisa Moriguchi; Hironori Mitsuyoshi; Kohichiroh Yasui; Masahito Minami; Yoshito Itoh
Journal:  J Gastroenterol       Date:  2015-01-28       Impact factor: 7.527

2.  Carotid artery intima-media thickness in patients with autoimmune connective tissue diseases: a case-control study.

Authors:  Vincenzo Bruzzese; Cinzia Marrese; Angelo Zullo; Cesare Hassan; Lorenzo Ridola; Annamaria Izzo; Camillo Riccioni
Journal:  Intern Emerg Med       Date:  2011-10-28       Impact factor: 3.397

Review 3.  Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.

Authors:  Traci L Testerman; James Morris
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Leptospirosis is associated with markedly increased triglycerides and small dense low-density lipoprotein and decreased high-density lipoprotein.

Authors:  Irene F Gazi; Fotini A Apostolou; Evangelos N Liberopoulos; Theodosios D Filippatos; Constantinos C Tellis; Moses S Elisaf; Alexandros D Tselepis
Journal:  Lipids       Date:  2011-06-19       Impact factor: 1.880

5.  Accumulation of Deleterious Effects in Gastric Epithelial Cells and Vascular Endothelial Cells In Vitro in the Milieu of Helicobacter pylori Components, 7-Ketocholesterol and Acetylsalicylic Acid.

Authors:  Adrian Ł Gajewski; Mateusz Gawrysiak; Agnieszka Krupa; Tomasz Rechciński; Maciej Chałubiński; Weronika Gonciarz; Magdalena Chmiela
Journal:  Int J Mol Sci       Date:  2022-06-06       Impact factor: 6.208

6.  Helicobacter pylori vs coronary heart disease - searching for connections.

Authors:  Magdalena Chmiela; Adrian Gajewski; Karolina Rudnicka
Journal:  World J Cardiol       Date:  2015-04-26

Review 7.  From the stomach to other organs: Helicobacter pylori and the liver.

Authors:  Marek Waluga; Michał Kukla; Michał Żorniak; Agata Bacik; Rafał Kotulski
Journal:  World J Hepatol       Date:  2015-08-28

Review 8.  Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease.

Authors:  Meng Li; Zhe Shen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

9.  High-density lipoprotein, low-density lipoprotein and triglyceride levels and upper gastrointestinal cancers risk: a trans-ancestry Mendelian randomization study.

Authors:  Yanling Wu; Junyi Xin; Elizabeth A Loehrer; Xia Jiang; Qianyu Yuan; David C Christiani; Hanping Shi; Lingxiang Liu; Shuwei Li; Meilin Wang; Haiyan Chu; Mulong Du; Zhengdong Zhang
Journal:  Eur J Clin Nutr       Date:  2022-01-21       Impact factor: 4.884

10.  Helicobacter pylori infection is identified as a cardiovascular risk factor in Central Africans.

Authors:  Benjamin Longo-Mbenza; Jacqueline Nkondi Nsenga; Etienne Mokondjimobe; Thierry Gombet; Itoua Ngaporo Assori; Jean Rosaire Ibara; Bertrand Ellenga-Mbolla; Dieudonné Ngoma Vangu; Simon Mbungu Fuele
Journal:  Vasc Health Risk Manag       Date:  2012-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.